Updates on world markets and companies news
Incoming chief executive Meg O’Neill will also have a larger cost-cutting goal as BP tries to cut debt
There are questions about M&A moves after NatWest bought Evelyn Partners
The company’s reliable oncology portfolio produced another year of growth for the UK pharma giant
John Rosier explains why he’s investing in a new theme but also boosting how much cash he holds
The Analyst: Robin Hardy outlines the best options in a booming sector
The Squeeze: The company thinks it’s at the forefront of innovation, but it’s cutting R&D spending
The bottling group has boosted its marketing spend to exploit events such as the Winter Olympics
Simon Thompson: The company is raising guidance, has record orders and a shrewd investor is building up a stake
The retailer’s first-half profits fell on higher operating costs